Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.
People Who Stop Taking GLP-1 Drugs Such As Ozempic and Wegovy Rapidly Gain Back Weight
New reporting documents the weight gain when people stop taking GLP-1 drugs such as Ozempic and Wegovy.